Search Results

There are 2094522 results for: content related to: Dabigatran and thrombolysis: A therapeutic dilemma

  1. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  2. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke

    Annals of Neurology

    Volume 71, Issue 5, May 2012, Pages: 624–633, Waltraud Pfeilschifter, Ferdinand Bohmann, Peter Baumgarten, Michel Mittelbronn, Josef Pfeilschifter, Edelgard Lindhoff-Last, Helmuth Steinmetz and Christian Foerch

    Version of Record online : 23 MAR 2012, DOI: 10.1002/ana.23558

  3. You have free access to this content
    A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 599–609, Paul K. L. Chin, Daniel F. B. Wright, David M. Patterson, Matthew P. Doogue and Evan J. Begg

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12364

  4. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  5. Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 12, December 2011, Pages: 1232–1249, Dr. Michael P. Gulseth, Dr. Ann K. Wittkowsky, Mr. John Fanikos, Dr. Sarah A. Spinler, Dr. William E. Dager and Dr. Edith A. Nutescu

    Version of Record online : 20 JAN 2012, DOI: 10.1592/phco.31.12.1232

  6. Dabigatran etexilate: What do hospitalists need to know?

    Journal of Hospital Medicine

    Volume 7, Issue 3, March 2012, Pages: 262–269, Amer Zeidan, Bishoy Faltas and Michael Streiff

    Version of Record online : 29 NOV 2011, DOI: 10.1002/jhm.996

  7. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  8. An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 901–909, Jo-Anne S. Wilson, Kerry B. Goralski, Steven D. Soroka, Matthew Morrison, Paula Mossop, Lekha Sleno, Yan Wang and David R. Anderson

    Version of Record online : 28 MAY 2014, DOI: 10.1002/jcph.335

  9. Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11, November 2008, Pages: 1354–1373, Dr. Brooke E. Baetz and Dr. Sarah A. Spinler

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.11.1354

  10. You have free access to this content
    The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 11, November 2015, Pages: 2087–2092, M. Jacquemin, J. Toelen, J. Schoeters, I. van Horenbeeck, I. Vanlinthout, M. Debasse, M. Peetermans, T. Vanassche, K. Peerlinck, J. van Ryn and P. Verhamme

    Version of Record online : 5 OCT 2015, DOI: 10.1111/jth.13138

  11. You have free access to this content
    Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin

    British Journal of Clinical Pharmacology

    Volume 74, Issue 3, September 2012, Pages: 490–500, Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer and Paul A. Reilly

    Version of Record online : 6 AUG 2012, DOI: 10.1111/j.1365-2125.2012.04218.x

  12. A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation

    Pacing and Clinical Electrophysiology

    Volume 36, Issue 2, February 2013, Pages: 172–179, TAKAMITSU NIN, AKINORI SAIRAKU, YUKIHIKO YOSHIDA, HIROKI KAMIYA, YASUSHI TATEMATSU, MAMORU NANASATO, YASUYA INDEN, HARUO HIRAYAMA and TOYOAKI MUROHARA

    Version of Record online : 4 NOV 2012, DOI: 10.1111/pace.12036

  13. Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 555–565, Dr Joachim Stangier, Dr Bengt I. Eriksson, Dr Ola E. Dahl, Dr Lennart Ahnfelt, Dr Gerhard Nehmiz, Hildegard Stähle, Dr Karin Rathgen and Dr Robbyna Svärd

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005274550

  14. You have free access to this content
    Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong

    Clinical Cardiology

    Volume 35, Issue 12, December 2012, Pages: E40–E45, Jason C. S. Ho, Andy M. Chang, Bryan P. Yan, Cheuk Man Yu, Yat Yin Lam and Vivian W. Y. Lee

    Version of Record online : 25 OCT 2012, DOI: 10.1002/clc.22069

  15. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 243–250, Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010393342

  16. You have free access to this content
    Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 630–638, Paul K. L. Chin, David M. Patterson, Mei Zhang, Berit P. Jensen, Daniel F. B. Wright, Murray L. Barclay and Evan J. Begg

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12366

  17. The Use of Dabigatran Immediately After Atrial Fibrillation Ablation

    Journal of Cardiovascular Electrophysiology

    Volume 23, Issue 3, March 2012, Pages: 264–268, ROGER A. WINKLE, R. HARDWIN MEAD, GREGORY ENGEL, MELISSA H. KONG and ROB A. PATRAWALA

    Version of Record online : 28 SEP 2011, DOI: 10.1111/j.1540-8167.2011.02175.x

  18. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Version of Record online : 19 NOV 2013, DOI: 10.1002/clc.22204

  19. You have free access to this content
    Poster Presentation

    International Journal of Stroke

    Volume 10, Issue S2, April 2015, Pages: 77–438,

    Version of Record online : 15 APR 2015, DOI: 10.1111/ijs.12479

  20. You have free access to this content
    Proceedings of the Thrombosis and Hemostasis summit of North America: Research abstracts

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S146–S200,

    Version of Record online : 10 APR 2012, DOI: 10.1002/ajh.23168